SERPINA1 and panniculitis: Ten case reports [61-68] and two clinical trials [69,70] have been found on intravenous AAT augmentation therapy in 12 patients with both AAT deficiency and one of the following diseases: vasculitis, panniculitis, fibromyalgia and bronchial asthma.